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OBSERVATIONS RELATED TO PATHOGENESIS OF DENGUE HEMORRHAGIC FEVER.
VI. HYPOTHESES AND DISCUSSION
A series of communications have described multidisciplinary studies of the
response of the host to dengue infection and observations on the biologic
attributes of dengue viruses isolated in Thailand during 1962-1964.1-2 This
paper attempts to integrate these and other observations into hypotheses of
dengue virus-human host interactions. In the first part of this paper, hy-
potheses and important observations are given with references to support-
ing data.t The discussion amplifies certain hypotheses, summarizing sup-
porting and conflicting observations and pointing to areas requiring further
study.
OBSERVATIONS AND HYPOTHESES
Human responses to dengue infection; "Normal" dengue
The manifestations of normal dengue illness are largely age dependent.
Disease is mild in children and more severe in adults. Infants and children
with dengue have syndromes ranging from a nonspecific fever to a mild
upper respiratory-like illness or gastroenteritis.2' These illnesses may be
accompanied at low frequency by such dengue-like findings as maculopapu-
lar rash, myalgia or lymphadenopathy. Older children and adults frequently
manifest dengue infection in the classical dengue syndrome: sudden onset
of fever, an early macular rash, headache, conjunctival injection, nausea,
vomiting, taste abnormalities, saddle-back fever, a late maculopapular rash,
generalized lymphadenopathy, post-illness bradycardia, asthenia, and in
some patients petechiae, epistaxis, positive tourniquet test or other hemor-
rhagic phenomena. '' If the patient with "normal" dengue seeks medical
attention, he generally does so early in his illness.' He has a marked leuko-
penia during the febrile period.2'8 Limited observations suggest that low-
grade thombocytopenia and liver enlargement may occur; the frequency of
such findings may vary with zirus type.1 19
There are no direct observations on the sites of virus replication in normal
dengue. Clinical findings, together with studies on other arboviral infec-
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tions,'"2 suggest the following pathogenetic scheme: dengue virus, follozwing
initialreplication at thesite ofarthropod bite orinregionallymphnodes, mul-
tiplies in vascular endothelium, especially in the epidermis. Some or all
dengue ziruses may multiply in certain cells in the liver, the bone marrow,
lymphopoetic tissue and muscle or connective tissue. Virus parasitized
cells are probably eliminated either by virus induced cytolysis or by de-
layed hypersensitivity. The elimination of virus parasitized cells late in the
course of the illness may be responsible for the second fever spike, the late
maculopapular rash and other post-illness phenomena. Hemorrhagic mani-
festations, which are observed at every stage of illness, are probably the
summation of ill-understood virus as well as host factors that result in the
incompetence of vascular endothelium.
Altered* dengue
Some patients, after manifesting normal dengue symptoms for several
days, abruptly become more ill. These patients may complain of abdominal
pain, inappetance and weakness and manifest restlessness, irritability, and
in some instances, an enlarged liver, pneumonic infiltrates and phenomena
probably related to vascular damage, such as leakage of proteinaceous fluid
into intracellular and serosal spaces, thrombocytopenia, focal or generalized
hemorrhages, hypoalbuminemia, hemoconcentration, and shock."'
The term dengue hemorrhagic fever (DHF) has been used empirically
to describe these as well as the entire range of host responses to dengue
infection, including patients with normal dengue responses.' Terminologic
imprecision in the dengue diseases has been the cause of much confusion.
For this reason, the term "Dengue hemorrhagic fever" should be reserved
for dengue infection responses that clearly vary from the normal by an
objective measure. On the basis of published observations, the following
minimal criteria for dengue hemorrhagic fever are provisionally pro-
posed.L9"2
Dengue Hemorrhagic Fever. A dengue disease characterized by worsen-
ing of illness two or more days after onset of fever, wi,th hypoproteinemnia
(<S5.5 gm%) and one or more of the following hemostatic abnormalities:
thrombocytopenia (<100,000/mm3), prolonged bleeding time (>5 min-
utes), or elevated prothrombin time.
Dengue shock syndrome is a useful diagnostic and prognostic subgroup:
A dengue disease characterized by the above plus shock (hypotension or
pulse pressure .20 mm Hg) and hemoconcentration as evidenced by a
hemotocrit >20%o of convalescent value, usually with increase in serum
transaminases.
* Altered is used herein to mean "more severe."
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It is postulated that tissue damage in DHF is greatest at normal sites of
dengue replication and that cytotoxicity is mediated by an immunologic
mechanism. As a result of sudden cellular damage a sequence of patho-
physiologic disturbance occurs which, if not corrected, may result in
death."8 Altered dengue occurs in infants under one year of age and in
persons with a secondary dengue antibody response. Females older than
three years with secondary dengue manifest altered responses twice as fre-
quently as males.9 Disease severity may be regulated by the amount of
antigen-antibody complexing since in fatal cases there is absence of virus
and also titers of circulating antibody that are lower than expected.89
Lesions of the vascular system in DHF are notable for lack of inflam-
matory response. Occasionally, necrosis of vascular endothelium is seen.
Basement membranes are usually preserved. Perivascular infiltration with
mononuclear cells or neutrophils is seen rarely. In material from Thailand,
thrombi or platelet thrombi are observed only rarely.'9
Mechanisms in altered dengue
Normal dengue infection response is altered toward more severe disease
in individuals with pre-infection dengue antibody, passively acquired (pri-
mary infection DHF) or endogenously produced (secondary infection
DHF).9 In secondary infection DHF, the first dengue infection sensitizes
and the second elicits an altered infection response. Sequential infections
with two heterologous dengue viruses protect the individual against clinical
disease with the 3rd or 4th dengue virus types. Severity or frequency of
an altered dengue response is dependent upon: 1) the sequence of virus
types encountered by the individual; secondary infections with dengue
type 2 resulting in a higher ratio of shock to total secondary infection than
other virus types,9 and 2) the interval between eliciting and sensitizing in-
fection, probably occurring at a minimum of 3 months and a maximum of
5 years.10
Two independent antigen-antibody reactions may contribute to the al-
teration of infection responses. Serum antibody (probably IgG), which
complexes free virus and complement, may aggregate blood platelets and
result in thrombocytopenia without shock. Increased capillary fragility is
caused by an immune mechanism not measured by conventional serologic
techniques. Alternate hypotheses of the mechanism of capillary damage in
both prinary and secondary infection DHF are proposed: 1) Pre-infection
dengue antibody of an immunoglobulin type more abundant in females
than in males (IgA ?) complexes zwith virus produced during the initial
stages of infection. These complexes stimulate anti-complex antibody (ne-w
antibody, presumably IgM). As infection progresses, complexes and anti-
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complex antibody increase to critical cytotoxic levels. 2) Pre-infection anti-
body of an immunoglobulin type more abundant in femalees than males
promotes a destructive acceleration of the delayed hypersensitivity response.
DISCUSSION
The effect of infection sequence on disease response
From patients with secondary infection DHF and shock, dengue type 2
viruses were recovered seven and five times more frequently than dengue
types 1 and 3, respectively.9 Yet, in the same period and place (1962-1964,
Bangkok) 26, 27, and 24 dengue types 1, 2 and 3 viruses, respectively,
were recovered from patients with primary dengue infections.9 One ex-
planation of the association of dengue 2 with observed secondary infections
is that an infection sequence ending in type 2 is more severe.
Certain observations on the biological attributes of dengue 2 viruses are
consistent with this hypothesis:
a) Dengue 2 viruses are "better" antigens than other dengue viruses.
In systems where little, if any, dengue virus replication occurs, such as
peripheral inoculation of dengue viruses in adult mice, dengue 2 produced
antisera with higher log neutralization indices than did inoculation of
equivalent amounts of other dengue viruses.6"'
b) In cultures of primate kidney cells, dengue 2 virus produced plaques
more rapidly,' produced cytopathic effect more completely,7" and resulted
in higher yield of extracellular virus than other types of dengue viruses."''2
In rhesus monkeys, dengue 2 viruses produced higher concentrations and
longer periods of viremia than other dengue types studied.'
c) Antigenic analyses of dengue viruses have shown that dengue 2 was
more frequently neutralized by antisera to other dengue viruses than strains
of any other type.7
In accord with our hypothesis of the immunologic alteration of host
response, a virus that replicated to a greater total antigenic mass at a
critical stage in the illness or that complexed with a wider range of
heterologous dengue antibodies might be expected to elicit a sensitization
reaction more frequently than viruses without these attributes.
Sensitizing and eliciting infections
Since there are at least four antigenically distinct dengue virus types,
modification of dengue illness could conceivably occur during the second,
third, or fourth infection with heterologous viruses and each of these in-
fections would be expected to be accompanied by a secondary antibody
response. By means of a mathematical model of sequential dengue infection
rates, it was demonstrated that age-specific hospitalization rates observed
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for DHF in Bangkok "fit" predicted sequential infection rates only when
it was assumed that the second dengue infection elicited a hypersensitivity
reaction.' This conclusion is supported by the studies of Russell, et ad.'
who observed secondary infection dengue shock syndrome in four patients
who had been bled prior to their second infection. In their pre-shock syn-
drome sera these children had evidence of a single prior dengue infection
experience.
A gradual decline in overt dengue disease occurs during mid to late
childhood in the Bangkok population. From predicted age specific rates of
third and fourth dengue infections, the absence of dengue disease in these
age groups suggests that infection with any two dengue viruses protects
against clinical illness with other serotypes.?
Interval between infections
Hammon has suggested that simultaneous or near simultaneous dengue
infections may result in DHF." However, unless it is postulated that DHF
increases in severity with age, multiple simultaneous dengue infections
should result in an age-specific DHF hospitalization curve which would
resemble that for primary dengue infections (a monotonically decreasing
curve with the largest group either in children less than one or one year
old.) Furthermore, Sabin observed suppression of replication of one virus
when two dengue viruses were inoculated simultaneously in humans.'
It is not known whether closely spaced dengue infections can occur in
humans. It seems unlikely, as dengue 1 and 2 viruses and dengue 1 vaccine
have produced partial protection to heterologous dengue illness for a period
of up to 3 months."'
A few infants 5 and 6 months old have been observed with a clinical
diagnosis of DHF and secondary dengue antibody responses. These cases
suggest that the interval between sensitizing and eliciting infections can be
less than one year. From epidemiological considerations, the largest num-
ber of second dengue infections in Thai children probably occur at an in-
terval of approximately one year.'
Sex and age
In general, the rate of attack of overt infectious disease is higher in
males than females. It has been proposed that immunoglobulin and antibody
production may be genetically or hormonally controlled, with females being
more efficient producers of immunoglobulins than males.' Batchelor and
Chapmane showed that female mice developed antibody of a higher titer
following injection of ascites sarcoma than did male mice of the same
species. Washburn and co-workers' have suggested that there is a gene on
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the X chromosome that plays a role in the quantitative control of the pro-
duction of immunoglobulins. It was speculated that females with two such
genes might produce more antibody and thus have greater resistance to
disease. We investigated this possibility, comparing secondary response HI
titers in males and females.' No differences were observed, although for
reasons discussed, our data cannot be accepted as definitive.
Immunologic mechanisms of DHF
Cell mediated. Phenomena attributed to delayed hypersensitivity have
been observed at different stages of dengue illnesses. 1) The occurrence of
delayed hypersensitivity has been postulated to explain the late appearing
maculopapular rash seen in normal dengue fever.' 2) Turk "irritation
cells" seen frequently during the acute phase of DHF' could represent an
in vivo lymphoblast transformation to dengue antigen. 3) Sabin observed an
erythematous response at the site of subcutaneous inoculation of dengue
viruses in human volunteers.'3 Skin reactions were noted 3-5 days after
inoculation. During the second maculopapular rash the inoculation site was
conspicuously spared. The reaction could not be passively transferred by
serum, but transfer of cells was not attempted. The reaction could not be
re-elicited by subsequent inoculation of live virus into the site. Skin biop-
sies showed perivascular infiltration of mononuclear cells. The humans
employed in these experiments presumably had not been sensitized to
dengue antigen by previous infection experience. The observed reaction
thus may be analogous to the induction of delayed hypersensitivity by very
small quantities of protein antigens.' Such reactions precede development
of detectable circulating antibody and may be due to IgM.'
Despite strong evidence that delayed hypersensitivity occurs in dengue
infection, conventional delayed hypersensitivity is unlikely to mediate the
alteration of host response in dengue if pathogenic unity of primary and
secondary infection DHF is accepted. Transfer of sensitized lymphocytes
could not occur in the former group. Further, the pathological findings in
DHF are not consistent with those seen in delayed hypersensitivity states.
If delayed hypersensitivity reactions can be altered in the direction of
greater virulence by passively or endogenously acquired dengue antibody
heterologous to the infecting virus, this might be a pathogenetic mechanism
for both types of DHF.
Antibody mediated. IgG. Chanock, et al.' have shown an apparent associ-
ation between high levels of respiratory syncytial virus (RS) serum anti-
body of maternal origin and subsequent development in the infant of severe
lower respiratory tract disease during naturally acquired RS virus infec-
tions. This type of response was seen most frequently during the first three
355
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FIG. 1. Average annual age-specihc DHF hospitalization rates for infants under 1
year old. Bangkok, 1962-1964.
months of life. Since, from contemporary evidence, IgG is the predominant
immunoglobulin transferred from mother to child'"> it has been assumed
that IgG mediates the RS virus reaction."
Figure 1 shows the age distribution of children with primary infection
DHF. At 6-9 months, when most cases occur, maternal antibody is con-
sidered to be at levels non-protective for the infant. Our data suggest, in
opposition to Chanock's hypothesis, that in dengue, maternally acquired
IgG antibody protects at high concentration but sensitizes at low concentra-
tion.
Abnormal, severe disease has been described in children acquiring a
measles infection several years after vaccination with killed measles virus
356
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vaccine.' In this syndrome, reactions occur after serum antibodies have
waned to below detectable levels.'5 Severe reactions have also been observed
in children immunized with killed respiratory syncytial virus who subse-
quently acquired "wild" virus infections." Dengue, measles and RS virus
illnesses altered immunologically appear to have in common the occurrence
of infection when antibody levels have waned to low levels and severe
disease in the presence of large amounts of serum antibody produced at a
time when virus is still being released from cells.
Although only IgG dengue antibody has been found in secondary dengue"
a number of observations are inconsistent with the hypothesis that this im-
munoglobulin mediates DHF. For example, why does secondary infection
DHF occur in the presence of abundant antibody and under conditions of
antibody excess while primary infection DHF occurs in the presence of
low or undetectable serum antibody? If disease mechanisms are the same
in these two situations, then it would appear that serum antibody titers do
not reflect sensitizing antibody. Why should there be a delay in alteration
of disease course in DHF until 3-7 days after the onset of fever? In infants
whose sensitization reaction is presumably mediated by passively acquired
antibody, any possible amount of circulating virus needed to elicit a cyto-
toxic reaction should be reached during the ascendant phase of virus pro-
duction early in disease. If low levels of dengue antibody serve to alter in-
fection response, it is difficult to understand why similar phenomena are
not seen in other viral diseases since all passively acquired antibody de-
teriorates to nonprotective (i.e., sensitivity) levels before being finally
catabolized. Finally, why are no histopathologic lesions of IgG-mediated
hypersensitivity found?
IgE. DHF, in many respects, resembles anaphylactic shock. There is no
direct evidence to rule out IgE mediation of disease alteration; however,
DHF patients have no allergic stigmata and large doses of steroids, anti-
histamines and sympathomimetic drugs given during the shock phase have
failed to result in dramatic termination of symptoms,' and finally, passive
transfer of reagin-mediated allergies are known not to occur.'
IgA. Ainbender, et al. have observed higher ratios of serum IgA/IgG
in girls than in boys." If this reflects the quantity of viral antibody, there
is an intriguing possibility that sometime after infancy females could begin
to produce more IgA dengue antibodies than males. If these participate in
immuno-alteration of dengue, the observed sex distribution in this disease
can be explained. Since boys and girls would be expected passively to ac-
quire IgA equally, no sex difference would be expected in primary infection
DHF. This is the case."' It is also interesting that the hospitalization rate
for primary infection DHF is twice that at any other age.' Might this reflect
357
HALSTEADYALE JOURNAL OF BIOLOGY AND MEDICINE
the fact that infants modify dengue infections with antibody acquired from
females?
It is difficult to explain how an infant could acquire IgA dengue anti-
body since this immunoglobulin is thought to pass the placenta only in
small quantities,'8" is not absorbed from colostrum or human milk'0 and
further, has only a 2-day serum half life.' However, these experimental
data do not rule out the possibility that IgA could pass through the placenta
or could be absorbed through the gut and be fixed to tissues and therefore,
remain undetectable in serum. Both IgM and IgA, when passively acquired,
have short half-lives. For IgM it has been suggested that a steep decay
curve may result from rapid fixation of immunoglobulin to cells.' This may
also be true of IgA.
If IgA is acquired transplacentally or, especially, if IgA is absorbed for
a prolonged period during infancy from human milk and has physiological
activity outlasting IgG, an explanation of the age distribution of primary
infection DHF becomes possible. Maternal IgG dengue antibodies protect
the infant from dengue infection for 3-6 months. When this protection is no
longer afforded, sensitization reactions may occur. Sometime late during
the first year of life, IgA antibody, in turn, is eliminated.
IgM. Although the postulation of the production of antibodies to immune
complexes in DHF is purely speculative, such antibodies have been ob-
served experimentally.' During the early stages of cellular infection, viruses
released could form neo-antigenic complexes with pre-infection antibody.
This hypothesis is appealing because the delay in formation of new anti-
body to a new antigen suggests a reason for the delay in appearance of the
altered host response in the sequence of normal infection. The hypothesis
lends itself to test in experimental animals and possibly to direct observa-
tions in DHF patients.
Mechanisms of hemostatic abnormalities
McKay and Margaretten' and Fresh, et al." have suggested that hemo-
static defects in DHF are due to intravascular coagulation, resulting in
thrombocytopenia and depletion of clotting factors. In the studies of Weiss
and Halstead,' however, a decrease in clotting factors was observed in only
five of 27 thrombocytopenic patients with virologically confirmed DHF.
The diminution of factors II, V, VII and X, which are minimal, were
found in the patients with greatest elevations of transaminase and lactic
dehydrogenase and were probably related to liver disease. Fibrinogen
values, determined in four of these patients, were 180, 200, 200 and 130
mg%. While these findings do not preclude the possibility that disseminated
intravascular coagulation may occur in some cases of DHF, they do not
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suggest that this mechanism played a significant role in the 27 patients
studied.
CONCLUSIONS
The fact that most of the hypotheses in this and preceding papers derive
from observations made in a single country and by a single laboratory
serves to strengthen confidence in the correlations made from observations.
These same facts limit the universality of our data. Parallel studies in other
countries may answer some significant questions. Are DHF and DSS as
defined above satisfactory as minimal criteria for abnormal dengue every-
where? Do sex differences and primary infection DHF occur in other popu-
lations? Are there variations in clinical or physiologic manifestations of
primary or secondary dengue by virus type? Answers will require large
numbers of studied patients and virus isolation and identification techniques
standardized to the greatest degree practicable. Increasingly sophisticated
approaches to the physiologic, genetic, immunologic, and virologic aspects
of DHF should soon provide tests of the hypotheses tentatively offered.
When an acute systemic hypersensitivity reaction was first invoked in the
etiology in DHF in 1964, it appeared to be a solitary phenomenon in the
acute viral diseases.' Since then, man himself has severely altered illness
response by sensitizing individuals with killed virus preparations. The
pathogenetic mechanisms in these cases are unknown, but are superficially
analogous to DHF. It is unlikely that immuno-enhancement of naturally
acquired acute viral disease is a unique property of a single virus group.
Efforts should be directed toward the study of similar phenomena in the
etiology of other human diseases.
SUMMARY
Studies of dengue virus diseases in Southeast Asia suggest that normal
human responses to dengue infection are altered to a syndrome character-
ized by hemoconcentration, hypoproteinemia, abnormalities in hemostasis
and shock in some individuals with heterologous dengue antibody, passively
acquired, or endogenously produced. This reaction may occur more fre-
quently when dengue type 2 is the secondary infecting virus and the patient
is a female three years or older. Possible explanations for these phenomena
are discussed. Delayed hypersensitivity-like reactions occur in humans
inoculated for the first time with live dengue viruses, yet the occurrence of
large numbers of cases of dengue hemorrhagic fever (DHF) in infants
during the first year of life suggests that antibody and not sensitized cells
mediate dengue virus hypersensitivity in this age group. Although IgG is
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known to pass the placental barrier and is found at high titer in patients
during the shock phase of DHF, there is no histological evidence support-
ing the occurrence of known IgG-mediated hypersensitivity lesions, Arthus
or Schwartzman. In an attempt to construct unitary hypotheses of DHF
the following were postulated: Pre-illness dengue antibody may alter de-
layed hypersensitivity reactions to become more host destructive, or pre-
illness antibody may form complexes with viruses which are in themselves
antigenic. If anti-complex reactions were cytotoxic and involved an im-
munoglobulin found more frequently in females than males, the delay in
alteration of dengue illness, the increased prevalence of disease in secondari-
ly infected females and occurrence of DHF in persons sensitized actively
and passively might be explained.
It is proposed that the pathophysiologic disturbances in DHF occur at
sites of dengue virus replication, since most abnormalities observed in DHF
are exaggerations of host responses to primary dengue infection.
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